Eda Y, Takizawa M, Murakami T., Maeda H., Kimachi K., YonemuraH, Koyanagi S, Shiosaki K, Higuchi H, Makizumi K, Nakashima T ,Osatomi K., Tokiyoshi S, Matsushita S, Yamamoto N. Honda M.　Sequential immunization with V3 peptides from primary HIV-1 produces　cross-neutralizing antibodies against primary isolates with matching narrow　neutralization sequence motif.J. Virol.　80:5552-5562,2006.

Eda Y, Murakami T, Ami Y, Nakasone T, Takizawa M, Someya K,　Kaizu M, Izumi Y., Yoshino, N., Matsusita, S.,Higuchi, H., Matsui, H., Shinohara, K., Takeuchi, H., Koyanagi, S., Yamamoto, N. and Honda M. Anti-V3　humanized antibody KD-247 effectively suppresses ex vivo generation of human　immunodeficiency virus type 1 and affordssterile protection of monkeys　against a heterologous simian/human immunodeficiency virus infection. J. Virol.　80:5563-5570,　2006